First Report of Ventriculoperitoneal Shunt Infection due to Cyberlindnera fabianii

Jonathan Baghdadi1, Peera Hemarajata2, Romney Humphries2

  • 1Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Insights

This study reports the first case of a fungal central nervous system (CNS) infection caused by Cyberlindnera fabianii in an immunocompetent adult with a ventriculoperitoneal (VP) shunt. It highlights transient fungemia as a potential risk factor for invasive fungal CNS disease.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Neurology

Background:

  • Fungal central nervous system (CNS) infections carry high morbidity and mortality.
  • The role of transient fungemia in immunocompetent individuals with ventriculoperitoneal (VP) shunts leading to CNS infections is not well-established.
  • Cyberlindnera fabianii CNS infections are rare, with limited data on their clinical presentation, diagnosis, and treatment.

Purpose of the Study:

  • To report the first documented case of CNS infection caused by Cyberlindnera fabianii in an immunocompetent adult with a VP shunt.
  • To explore the potential mechanism of infection, including spontaneous translocation of yeast from the gastrointestinal tract.
  • To discuss the implications for diagnosis and management of such rare fungal CNS infections.

Main Methods:

  • Case report of an immunocompetent adult with a VP shunt who developed meningitis.
  • Identification of Cyberlindnera fabianii as the causative agent.
  • Analysis of potential sources of infection, including dietary factors.

Main Results:

  • A case of meningitis due to Cyberlindnera fabianii in an immunocompetent adult with a VP shunt is described.
  • Ingestion of fermented products was identified as a potential source for yeast translocation into the VP shunt system.
  • The patient experienced CNS infection despite having no other apparent risk factors for fungemia.

Conclusions:

  • Transient fungemia can lead to invasive fungal CNS disease in immunocompetent hosts with VP shunts, even without other risk factors.
  • Long-term antifungal therapy is crucial, especially when complete VP shunt removal is not feasible.
  • This case underscores the importance of considering fungal etiologies in VP shunt infections, even in immunocompetent patients.